CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 279 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,409,712 | -16.0% | 43,725 | +13.2% | 0.27% | -12.8% |
| Q2 2023 | $5,250,813 | +5.9% | 38,640 | -59.5% | 0.31% | -0.9% |
| Q1 2023 | $4,960,219 | +116721.0% | 95,422 | +99.2% | 0.32% | +6.4% |
| Q4 2022 | $4,246 | -99.9% | 47,906 | -1.2% | 0.30% | +4.6% |
| Q3 2022 | $3,886,000 | -11.5% | 48,471 | +5.7% | 0.28% | +1.8% |
| Q2 2022 | $4,391,000 | -36.5% | 45,853 | -1.5% | 0.28% | -22.7% |
| Q1 2022 | $6,916,000 | +10.0% | 46,558 | +5.0% | 0.36% | +18.8% |
| Q4 2021 | $6,285,000 | -10.7% | 44,335 | -17.6% | 0.30% | -13.6% |
| Q3 2021 | $7,041,000 | -1.5% | 53,820 | +3.5% | 0.35% | -1.7% |
| Q2 2021 | $7,148,000 | +7.7% | 52,011 | +2.3% | 0.36% | +3.2% |
| Q1 2021 | $6,639,000 | +16.5% | 50,840 | -0.1% | 0.35% | +22.6% |
| Q4 2020 | $5,701,000 | -17.1% | 50,904 | -41.7% | 0.28% | -18.9% |
| Q3 2020 | $6,873,000 | +7.4% | 87,365 | -1.7% | 0.35% | +2.3% |
| Q2 2020 | $6,400,000 | – | 88,903 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |